BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23241394)

  • 1. Treatment of fracture non-union in a young adult with combination anabolic and anti-resorptive bone therapy.
    Corrigan RA; Miller A; McNally MA; Javaid MK
    Rheumatology (Oxford); 2013 Jun; 52(6):1147-9. PubMed ID: 23241394
    [No Abstract]   [Full Text] [Related]  

  • 2. Teriparatide as a nonoperative treatment for tibial and femoral fracture nonunion: A case report.
    Xiaofeng L; Daxia X; Yunzhen C
    Medicine (Baltimore); 2017 Apr; 96(16):e6571. PubMed ID: 28422848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate.
    Schindeler A; Birke O; Yu NY; Morse A; Ruys A; Baldock PA; Little DG
    J Bone Joint Surg Br; 2011 Aug; 93(8):1134-9. PubMed ID: 21768643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy.
    Chiang CY; Zebaze RM; Ghasem-Zadeh A; Iuliano-Burns S; Hardidge A; Seeman E
    Bone; 2013 Jan; 52(1):360-5. PubMed ID: 23072919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophic humeral shaft nonunion treated with teriparatide (rh PTH 1-34): a case report.
    Oteo-Alvaro A; Moreno E
    J Shoulder Elbow Surg; 2010 Oct; 19(7):e22-8. PubMed ID: 20846618
    [No Abstract]   [Full Text] [Related]  

  • 6. The relative merits of anabolics versus anti-resorptive compounds: where our targets should be, and whether we are addressing them.
    Gasser JA
    Curr Opin Pharmacol; 2006 Jun; 6(3):313-8. PubMed ID: 16650802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture.
    Mognetti B; Marino S; Barberis A; Martin AS; Bala Y; Di Carlo F; Boivin G; Barbos MP
    Calcif Tissue Int; 2011 Aug; 89(2):163-71. PubMed ID: 21701938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparitide update.
    Silverman SL; Nasser K
    Rheum Dis Clin North Am; 2011 Aug; 37(3):471-7, vii. PubMed ID: 22023903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone fracture and the healing mechanisms. The effects of anti-resorptive agents on fracture healing].
    Mashiba T; Mori S
    Clin Calcium; 2009 May; 19(5):673-9. PubMed ID: 19398835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site specific effects of zoledronic acid during tibial and mandibular fracture repair.
    Yu YY; Lieu S; Hu D; Miclau T; Colnot C
    PLoS One; 2012; 7(2):e31771. PubMed ID: 22359627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teriparatide as a systemic treatment for lower extremity nonunion fractures: a case series.
    Mancilla EE; Brodsky JL; Mehta S; Pignolo RJ; Levine MA
    Endocr Pract; 2015 Feb; 21(2):136-42. PubMed ID: 25297667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improvement of fracture healing with teriparatide: series of 22 cases and review of the literature].
    Lecoultre J; Stoll D; Chevalley F; Lamy O
    Rev Med Suisse; 2015 Mar; 11(466):663-7. PubMed ID: 25962228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of aseptic nonunions with parathyroid hormone.
    Kastirr I; Reichardt M; Andresen R; Radmer S; Schröder G; Westphal T; Mittlmeier T; Schober HC
    Eur J Orthop Surg Traumatol; 2019 Jan; 29(1):169-173. PubMed ID: 29931529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological analysis of bone dynamics and metabolic bone disease. Histological findings in animal fracture model--effects of osteoporosis treatment drugs on fracture healing process].
    Mashiba T
    Clin Calcium; 2011 Apr; 21(4):551-8. PubMed ID: 21447922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients.
    Calori GM; Tagliabue L; Gala L; d'Imporzano M; Peretti G; Albisetti W
    Injury; 2008 Dec; 39(12):1391-402. PubMed ID: 19027898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of sternal fracture nonunion with teriparatide.
    Chintamaneni S; Finzel K; Gruber BL
    Osteoporos Int; 2010 Jun; 21(6):1059-63. PubMed ID: 19859645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human bone morphogenic protein-7: applications for clinical trauma.
    McKee MD
    J Orthop Trauma; 2005; 19(10 Suppl):S26-8. PubMed ID: 16479220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly teriparatide administration for the treatment of delayed union: a report of two cases.
    Tachiiri H; Okuda Y; Yamasaki T; Kusakabe T
    Arch Osteoporos; 2014; 9():179. PubMed ID: 24777526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healing of the bone with anti-fracture drugs.
    Vannucci L; Brandi ML
    Expert Opin Pharmacother; 2016 Dec; 17(17):2267-2272. PubMed ID: 27673358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion of PTH
    Yukata K; Kanchiku T; Egawa H; Nakamura M; Nishida N; Hashimoto T; Ogasa H; Taguchi T; Yasui N
    Sci Rep; 2018 Sep; 8(1):13175. PubMed ID: 30181648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.